Among the various public portfolio startups of the fund, we may underline Cylene Pharmaceuticals Among the most successful fund investment fields, there are Biotechnology, Health Care. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the TDL Investors, startups are often financed by Sanderling Ventures, RCT BioVentures, Novartis Venture Fund. The meaningful sponsors for the fund in investment in the same round are William Harris Investors, Viterbi Group, Mitsui Global Investment. In the next rounds fund is usually obtained by Lilly Ventures, HBM Healthcare Investments AG, Bioventures Investors.
The top activity for fund was in 2005. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
| Fund Name | Location |
| All Blue Capital | New York, New York, United States |
| Angel | - |
| Asia Alpha | - |
| Brookstone | Merrimack, New Hampshire, United States |
| Democracy Fund | District of Columbia, United States, Washington |
| DH Capital | New York, New York, United States |
| Ethereum Classic Labs | California, San Francisco, United States |
| Harcourts Paramount | Gregory, South Dakota, United States |
| LIC AgCelerator | Hamilton, New Zealand, Waikato |
| Mercura Capital | Bayern, Germany, Muenchen |
| Navistar | Illinois, Lisle, United States |
| Orrick | California, San Francisco, United States |
| Reinvent Capital | New York, New York, United States |
| StepStone Group | California, La Jolla, United States |
| Taiwan Advanced Materials Technologies Corp | China, Jiangsu, Taiwan |
| TUI Group | Germany, Hanover, Niedersachsen |
| UUI Ventures | - |
| Work Space | Glasgow, Glasgow City, United Kingdom |
| Ww Ventures | England, Reading, United Kingdom |
| Zhongshan Venture Capital | Chengguan District, China, Lhasa |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cylene Pharmaceuticals | $26M | 26 May 2005 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cylene Pharmaceuticals | $26M | 26 May 2005 | San Diego, California, United States |
